High-throughput screening of stem cell therapy for globoid cell leukodystrophy using automated neurophenotyping of twitcher mice

Behavioural Brain Research

Volumn 236, Issue 1, 2013, Pages 35-47

  Scruggs, Brittni A ^a   Bowles, Annie C ^b   Zhang, Xiujuan ^a   Semon, Julie A ^a   Kyzar, Evan J ^a   Myers, Leann ^c   Kalueff, Allan V ^a   Bunnell, Bruce A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

Behavioral phenotype; EthoVision XT7; Globoid cell leukodystrophy; Mesenchymal stem stromal cells; Noldus technology; Twitcher mouse

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; EXPLORATORY BEHAVIOR; GAIT; GENOTYPE; GLOBOID CELL LEUKODYSTROPHY; GROOMING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; LOCOMOTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCIATIC NERVE; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; GREEN FLUORESCENT PROTEINS; GROOMING; HIGH-THROUGHPUT SCREENING ASSAYS; INJECTIONS, INTRAPERITONEAL; LEUKODYSTROPHY, GLOBOID CELL; LIFE EXPECTANCY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MOTOR ACTIVITY; PHENOTYPE; PSYCHOMOTOR PERFORMANCE; STEM CELL TRANSPLANTATION;

EID: 84865980037     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.08.020     Document Type: Article

References (55)

1. Suzuki K., Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proceedings of the National Academy of Sciences of the United States of America 1970, 66(June (2)):302-309.
2. Kolodny E.H. Globoid Leukodystrophy 1996, Elsevier Science.
3. Rafi M.A., Zhi Rao H., Passini M.A., Curtis M., Vanier M.T., Zaka M., et al. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Molecular Therapy 2005, 11(May (5)):734-744.
4. Sakai N. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment. Brain and Development 2009, 31(August (7)):485-487.
5. Svennerholm L., Vanier M.T., Mansson J.E. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. Journal of Lipid Research 1980, 21(January (1)):53-64.
6. De Gasperi R., Gama Sosa M.A., Sartorato E.L., Battistini S., MacFarlane H., Gusella J.F., et al. Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy. American Journal of Human Genetics 1996, 59(December (6)):1233-1242.
7. Suzuki K., Taniike M. Murine model of genetic demyelinating disease: the twitcher mouse. Microscopy Research and Technique 1995, 32(October (3)):204-214.
8. Suzuki K., Suzuki K. The twitcher mouse: a model for Krabbe disease and for experimental therapies. Brain Pathology (Zurich, Switzerland) 1995, 5(July (3)):249-258.
9. Kobayashi T., Yamanaka T., Jacobs J.M., Teixeira F., Suzuki K. The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Research 1980, 202(December (2)):479-483.
10. Wenger D.A. Murine, canine and non-human primate models of Krabbe disease. Molecular Medicine Today 2000, November (6)(11):449-451.
11. Biswas S., Biesiada H., Williams T.D., LeVine S.M. Delayed clinical and pathological signs in twitcher (globoid cell leukodystrophy) mice on a C57BL/6×CAST/Ei background. Neurobiology of Disease 2002, 10(August (3)):344-357.
12. LeVine S.M., Pedchenko T.V., Bronshteyn I.G., Pinson D.M. l-cycloserine slows the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice). Journal of Neuroscience Research 2000, 60(April (2)):231-236.
13. Lin D., Donsante A., Macauley S., Levy B., Vogler C., Sands M.S. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Molecular Therapy 2007, 15(January (1)):44-52.
14. Miranda C.O., Teixeira C.A., Liz M.A., Sousa V.F., Franquinho F., Forte G., et al. Systemic delivery of bone marrow-derived mesenchymal stromal cells diminishes neuropathology in a mouse model of Krabbe's disease. Stem Cells 2011, 29(November (11)):1738-1751.
15. Ripoll C.B., Flaat M., Klopf-Eiermann J., Fisher-Perkins J.M., Trygg C.B., Scruggs B.A., et al. Mesenchymal-lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease. Stem Cells 2011, 29(January (1)):67-77.
16. Wicks S.E., Londot H., Zhang B., Dowden J., Klopf-Eiermann J., Fisher-Perkins J.M., et al. Effect of intrastriatal mesenchymal stromal cell injection on progression of a murine model of Krabbe disease. Behavioural Brain Research 2011, 225(December (2)):415-425.
17. Lin D., Fantz C.R., Levy B., Rafi M.A., Vogler C., Wenger D.A., et al. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. Molecular Therapy 2005, 12(September (3)):422-430.
18. Olmstead C.E. Neurological and neurobehavioral development of the mutant 'twitcher' mouse. Behavioural Brain Research 1987, 25(August (2)):143-153.
19. Lee W.C., Courtenay A., Troendle F.J., Stallings-Mann M.L., Dickey C.A., DeLucia M.W., et al. Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy. FASEB Journal 2005, 19(September (11)):1549-1551.
20. Matsushima G.K., Taniike M., Glimcher L.H., Grusby M.J., Frelinger J.A., Suzuki K., et al. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell 1994, 78(August (4)):645-656.
21. Kyzar E., Gaikwad S., Roth A., Green J., Pham M., Stewart A., et al. Towards high-throughput phenotyping of complex patterned behaviors in rodents: focus on mouse self-grooming and its sequencing. Behavioural Brain Research 2011, 225(December (2)):426-431.
22. Moscardo E., Rostello C. An integrated system for video and telemetric electroencephalographic recording to measure behavioural and physiological parameters. Journal of Pharmacological and Toxicological Methods 2010, 62(July-August (1)):64-71.
23. Noldus L.P., Spink A.J., Tegelenbosch R.A. EthoVision: a versatile video tracking system for automation of behavioral experiments. Behavior Research Methods Instruments & Computers. 2001, 33(August (3)):398-414.
24. Spink A.J., Tegelenbosch R.A., Buma M.O., Noldus L.P. The EthoVision video tracking system-a tool for behavioral phenotyping of transgenic mice. Physiology and Behavior 2001, 73(August (5)):731-744.
25. Terrell K.A., Rasmussen T.A., Trygg C., Bunnell B.A., Buck W.R. Molecular beacon genotyping for globoid cell leukodystrophy from hair roots in the twitcher mouse and rhesus macaque. Journal of Neuroscience Methods 2007, 163(June (1)):60-66.
26. Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., et al. Fiji: an open-source platform for biological-image analysis. Nature Methods 2012, 9(7):676-682.
27. Kalueff A.V., Fox M.A., Gallagher P.S., Murphy D.L. Hypolocomotion anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain and Behavior 2007, 6(June (4)):389-400.
28. Christomanou H., Jaffe S., Martinius J., Cap C., Betke K. Biochemical, genetic, psychometric, and neuropsychological studies in heterozygotes of a family with globoid cell leucodystrophy (Krabbe's disease). Human Genetics 1981, 58(2):179-183.
29. Farrimond J.A., Hill A.J., Jones N.A., Stephens G.J., Whalley B.J., Williams C.M. A cost-effective high-throughput digital system for observation and acquisition of animal behavioral data. Behavior Research Methods 2009, 41(May (2)):446-451.
30. Meyerrose T.E., Roberts M., Ohlemiller K.K., Vogler C.A., Wirthlin L., Nolta J.A., et al. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells 2008, 26(July (7)):1713-1722.
31. Lanz T.V., Opitz C.A., Ho P.P., Agrawal A., Lutz C., Weller M., et al. Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Stem Cells and Development 2010, 19(May (5)):657-668.
32. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research 1999, 835(July (1)):18-26.
33. Miller B.H., Schultz L.E., Gulati A., Su A.I., Pletcher M.T. Phenotypic characterization of a genetically diverse panel of mice for behavioral despair and anxiety. PLoS One 2010, 5(12):e14458.
34. Kalueff A.V., Aldridge J.W., LaPorte J.L., Murphy D.L., Tuohimaa P. Analyzing grooming microstructure in neurobehavioral experiments. Nature Protocols 2007, 2(10):2538-2544.
35. Sachs B.D. The development of grooming and its expression in adult animals. Annals of the New York Academy of Sciences 1988, 525:1-17.
36. Kalueff A.V., Tuohimaa P. Contrasting grooming phenotypes in C57Bl/6 and 129S1/SvImJ mice. Brain Research 2004, 1028(November (1)):75-82.
37. Kalueff A.V., Tuohimaa P. Contrasting grooming phenotypes in three mouse strains markedly different in anxiety and activity (129S1, BALB/c and NMRI). Behavioural Brain Research 2005, 160(May (1)):1-10.
38. Coscia E.M., Fentress J.C. Neurological dysfunction expressed in the grooming behavior of developing weaver mutant mice. Behavior Genetics 1993, 23(November (6)):533-541.
39. Uccelli A., Benvenuto F., Laroni A., Giunti D. Neuroprotective features of mesenchymal stem cells. Best Practice and Research. Clinical Haematology 2011, 24(March (1)):59-64.
40. Chen X., Armstrong M.A., Li G. Mesenchymal stem cells in immunoregulation. Immunology and Cell Biology 2006, 84(October (5)):413-421.
41. Hardy S.A., Maltman D.J., Przyborski S.A. Mesenchymal stem cells as mediators of neural differentiation. Current Stem Cell Research Therapy 2008, 3(January (1)):43-52.
42. Croitoru-Lamoury J., Williams K.R., Lamoury F.M., Veas L.A., Ajami B., Taylor R.M., et al. Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. Cytotherapy 2006, 8(5):445-458.
43. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells for regenerative medicine. Circulation Research 2007, 100(May (9)):1249-1260.
44. Koc O.N., Peters C., Aubourg P., Raghavan S., Dyhouse S., DeGasperi R., et al. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Experimental Hematology 1999, 27(November (11)):1675-1681.
45. Duchen L.W., Eicher E.M., Jacobs J.M., Scaravilli F., Teixeira F. Hereditary leucodystrophy in the mouse: the new mutant twitcher. Brain 1980, 103(September (3)):695-710.
46. Smith B., Galbiati F., Cantuti-Castelvetri L., Givogri M.I., Lopez-Rosas A., Bongarzone E.R. Peripheral neuropathy in the Twitcher mouse involves the activation of axonal caspase 3. American Society for Neurochemistry 2011, 3(September (4)):213-222.
47. Scaravilli F., Suzuki K. Enzyme replacement in grafted nerve of twitcher mouse. Nature 1983, 305(October (5936)):713-715.
48. Duffner P.K., Barczykowski A., Jalal K., Yan L., Kay D.M., Carter R.L. Early infantile Krabbe disease: results of the world-wide Krabbe registry. Pediatric Neurology 2011, 45(September (3)):141-148.
49. Duffner P.K., Barczykowski A., Kay D.M., Jalal K., Yan L., Abdelhalim A., et al. Later onset phenotypes of Krabbe disease: results of the world-wide registry. Pediatric Neurology 2012, 46(May (5)):298-306.
50. Barone R., Brühl K., Stoeter P., Fiumara A., Pavone L., Beck M. Clinical and neuroradiological findings in classic infantile and late-onset globoid-cell leukodystrophy (Krabbe disease). American Journal of Medical Genetics 1996, 63(May (1)):209-217.
51. Zafeiriou D.I., Anastasiou A.L., Michelakaki E.M., Augoustidou-Savvopoulou P.A., Katzos G.S., Kontopoulos E.E. Early infantile Krabbe disease: deceptively normal magnetic resonance imaging and serial neurophysiological studies. Brain and Development 1997, 19(November (7)):488-491.
52. Sasaki M., Sakuragawa N., Takashima S., Hanaoka S., Arima M.M.R.I. CT findings in Krabbe disease. Pediatric Neurology 1991, 7(July-August (4)):283-288.
53. Puckett R.L., Orsini J.J., Pastores G.M., Wang R.Y., Chang R., Saavedra-Matiz C.A., et al. Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards. Molecular Genetics and Metabolism 2012, 105(January (1)):126-131.
54. Hagberg B., Kollberg H., Sourander P., Akesson H.O. Infantile globoid cell leucodystrophy (Krabbe's disease). A clinical and genetic study of 32 Swedish cases 1953-1967. Neuropadiatrie 1969, 1(June-July (1)):74-88.
55. Brownsworth R.D., Bodensteiner J.B., Schaefer G.B., Barnes P. Computed tomography and magnetic resonance imaging in late-onset globoid cell leukodystrophy (Krabbe disease). Pediatric Neurology 1985, 1(July-August (4)):242-244.